Literature DB >> 9140999

Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease.

M Gotoh1, S Nagase, K Aoyagi, A Hirayama, K Takemura, A Ueda, C Tomida, H Kikuchi, A Koyama.   

Abstract

BACKGROUND: Patients with end-stage renal disease are thought to be in a highly peroxidative state, based on studies showing decreased serum antioxidant activity and increased peroxidative products. In this study we confirm these findings by examining lipid peroxidation in subcutaneous fat tissue in uraemia. SUBJECTS AND METHODS: Twenty-seven subcutaneous fat samples were taken from patients with end-stage renal disease when they underwent intervention for arteriovenous fistula for haemodialyis or for catheter insertion for continuous ambulatory peritoneal dialysis. The control samples were taken from 11 patients with normal renal function and without any history of renal disease who had surgical interventions. Lipid peroxides were measured as thiobarbituric acid reactive substance.
RESULTS: The concentration of thiobarbituric acid reactive substances in subcutaneous fat tissue in the patients with end-stage renal disease is 1.223 +/- 0.636 nmol/mg fat tissue (mean +/- SD) whereas the level in the control group is 0.097 +/- 0.054 nmol/mg fat tissue. A comparison of the two groups by Student's t test revealed a highly significant difference (P < 0.001).
CONCLUSIONS: This study supports the finding of a severe peroxidative state in patients with end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140999     DOI: 10.1093/ndt/12.4.713

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

1.  The effects of 1-year treatment with a haemodiafiltration with on-line regeneration of ultrafiltrate (HFR) dialysis on biomarkers of oxidative stress in patients with chronic renal failure.

Authors:  B González-Diez; M Cavia; G Torres; P Abaigar; V Camarero; P Muñiz
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

2.  Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical.

Authors:  Atsushi Ueda; Sohji Nagase; Hidekatsu Yokoyama; Mika Tada; Hiroyuki Noda; Hiroaki Ohya; Hitoshi Kamada; Aki Hirayama; Akio Koyama
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

3.  A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy.

Authors:  Srinivasan Beddhu; Rebecca Filipowicz; Bin Wang; Guo Wei; Xiaorui Chen; Abinash C Roy; Scott L DuVall; Hanadi Farrukh; Arsalan N Habib; Terrence Bjordahl; Debra L Simmons; Mark Munger; Greg Stoddard; Donald E Kohan; Tom Greene; Yufeng Huang
Journal:  Can J Kidney Health Dis       Date:  2016-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.